Extending Positron Emission Tomography Scan Utility to High-Risk Neuroblastoma: Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as Sole Imaging Modality in Follow-Up of Patients
作者： Brian H. Kushner , Henry W.D. Yeung , Steven M. Larson , Kim Kramer , Nai-Kong V. Cheung
DOI: 10.1200/JCO.2001.19.14.3397
关键词:
摘要: PURPOSE: Although positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (18F-FDG) has a major impact on the treatment of adult cancer, reported experience extracranial tumors childhood is limited. We describe role for PET in patients neuroblastoma (NB). PATIENTS AND METHODS: In 51 high-risk NB, 92 scans were part staging evaluation that included iodine-123 or iodine-131 metaiodobenzylguanidine (MIBG) scan, bone computed (and/or magnetic resonance imaging), urine catecholamine measurements, and marrow (BM) examinations. The minimum number tests sufficient to detect NB was determined. RESULTS: Of 40 who not complete remission, only 1 (2.5%) had would have been missed limited BM studies, 13 (32.5%) detected by but tests. equal superior MIBG identifying soft tissue skeletal structu...
sci-hub.se 参考文章(21)
N K Cheung, G Heller, B H Kushner, C Liu, I Y Cheung, Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive? Journal of Clinical Oncology. ,vol. 15, pp. 2807- 2817 ,(1997) , 10.1200/JCO.1997.15.8.2807
Brian H. Kushner, Leslie Burch, Michael Laquaglia, Ronald Finn, Samuel D. J. Yeh, Nai-Kong V. Cheung, Steven M. Larson, Radioimmunodetection of Neuroblastoma with Iodine-131-3F8: Correlation with Biopsy, Iodine-131-Metaiodobenzylguanidine and Standard Diagnostic Modalities The Journal of Nuclear Medicine. ,vol. 32, pp. 769- 776 ,(1991)
SAMUEL D. J. YEH, LAWRENCE HELSON, RICHARD S. BENUA, Correlation between iodine-131 MIBG imaging and biological markers in advanced neuroblastoma. Clinical Nuclear Medicine. ,vol. 13, pp. 46- 52 ,(1988) , 10.1097/00003072-198801000-00014
EGLAL SHALABY-RANA, MASSOUD MAJD, MARY P. ANDRICH, NASSER MOVASSAGHI, In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome Clinical Nuclear Medicine. ,vol. 22, pp. 315- 319 ,(1997) , 10.1097/00003072-199705000-00008
U. Feine, W. Müller-Schauenburg, J. Treuner, T H. Klingebiel, Metaiodobenzylguanidine (MIBG) labeled with123I/131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the international workshop of pediatric oncology held in Rome, september 1986 Medical and Pediatric Oncology. ,vol. 15, pp. 181- 187 ,(1987) , 10.1002/MPO.2950150408
Alfred Grovas, Amy Fremgen, Amanda Rauck, Frederick B. Ruymann, Carol L. Hutchinson, David P. Winchester, Herman R. Menck, The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer. ,vol. 80, pp. 2321- 2332 ,(1997) , 10.1002/(SICI)1097-0142(19971215)80:12<2321::AID-CNCR14>3.0.CO;2-W
B L Shulkin, D S Mitchell, D R Ungar, D Prakash, M G Dole, V P Castle, R J Hernandez, R A Koeppe, R J Hutchinson, Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies. Radiology. ,vol. 194, pp. 495- 500 ,(1995) , 10.1148/RADIOLOGY.194.2.7824731
P. Rigo, P. Paulus, B. J. Kaschten, R. Hustinx, T. Bury, G. Jerusalem, T. Benoit, J. Foidart-Willems, Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 23, pp. 1641- 1674 ,(1996) , 10.1007/BF01249629
B L Shulkin, R J Hutchinson, V P Castle, G A Yanik, B Shapiro, J C Sisson, Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology. ,vol. 199, pp. 743- 750 ,(1996) , 10.1148/RADIOLOGY.199.3.8637999
Robin Corbett, Julie Olliff, Neil Fairley, Judy Moyes, Janet Husband, Ross Pinkerton, Richard Carter, Jennifer Treleaven, Timothy McElwain, Simon Meller, A prospective comparison between magnetic resonance imaging, meta-iodobenzylguanidine scintigraphy and marrow histology/cytology in neuroblastoma. European Journal of Cancer and Clinical Oncology. ,vol. 27, pp. 1560- 1564 ,(1991) , 10.1016/0277-5379(91)90415-A